ID: ALA4536191

Max Phase: Preclinical

Molecular Formula: C20H17N3

Molecular Weight: 299.38

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  c1ccc(Cn2c(Nc3ccccc3)nc3ccccc32)cc1

Standard InChI:  InChI=1S/C20H17N3/c1-3-9-16(10-4-1)15-23-19-14-8-7-13-18(19)22-20(23)21-17-11-5-2-6-12-17/h1-14H,15H2,(H,21,22)

Standard InChI Key:  QQZALSKVCZVWBY-UHFFFAOYSA-N

Associated Targets(non-human)

Short transient receptor potential channel 5 64 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 299.38Molecular Weight (Monoisotopic): 299.1422AlogP: 4.83#Rotatable Bonds: 4
Polar Surface Area: 29.85Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.89CX LogP: 5.33CX LogD: 5.22
Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.58Np Likeness Score: -1.33

References

1. Sharma SH, Pablo JL, Montesinos MS, Greka A, Hopkins CR..  (2019)  Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.,  29  (2): [PMID:30538066] [10.1016/j.bmcl.2018.12.007]

Source